# Arbutus Biopharma Corp: Form 8-K, filed Aug 26, 2019

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2019-08-26
- Accepted by EDGAR: Aug 26, 2019, 16:14 ET
- Period: 2019-08-26
- Accession: 0001447028-19-000060
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000144702819000060/a2019-08x26x8xkubclegalset.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000144702819000060/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000144702819000060/a2019-08x26x8xkubclegalset.htm

Filed Aug 26, 2019.
Source: SEC EDGAR, the filing index for accession 0001447028-19-000060. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
